BioNxt Solutions Inc. (OTCMKTS:BNXTF) Stock Short Interest Report for September

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant increase in short interest in September. As of September 30th, there was short interest totaling 6,000 shares, an increase of 500.0% from the September 15th total of 1,000 shares. Based on an average daily trading volume, of 460 shares, the days-to-cover ratio is currently 13.0 days. Approximately 0.0% of the company’s stock are sold short.

BioNxt Solutions Price Performance

BioNxt Solutions stock opened at $0.26 on Monday. The company has a 50 day moving average of $0.25 and a 200-day moving average of $0.28. BioNxt Solutions has a twelve month low of $0.14 and a twelve month high of $0.79. The stock has a market capitalization of $35.61 million, a PE ratio of -5.23 and a beta of 0.70.

BioNxt Solutions (OTCMKTS:BNXTF) last issued its quarterly earnings data on Friday, August 28th. The company reported ($0.01) EPS for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc is a life sciences company focused on developing drug-delivery and diagnostic technologies. The company’s platform areas include orally dissolvable thin-film formulations, transdermal delivery systems and diagnostic products designed to support more convenient and efficient administration of pharmaceutical treatments.

BioNxt’s development programs have included oral thin-film versions of established pharmaceutical compounds, as well as technologies intended for applications in neurological, infectious-disease and other therapeutic areas.